 | Up a level |
Chong, Huey Yi and Lim, Kheng-Seang and Fong, Si-Lei and Shabaruddin, Fatiha Hana and Dahlui, Maznah and Mei Lai, Pauline Siew and Ng, Ching-Ching and Chaiyakunapruk, Nathorn (2023) Integrating real-world data in cost-effectiveness analysis of universal HLA-B15:02 screening in Malaysia. British Journal of Clinical Pharmacology, 89 (11). pp. 3340-3351. ISSN 0306-5251, DOI https://doi.org/10.1111/bcp.15818.
Snyder, Susan R. and Hao, Jing and Cavallari, Larisa H. and Geng, Zhi and Elsey, Amanda and Johnson, Julie A. and Mohamed, Zahurin and Chaiyakunapruk, Nathorn and Chong, Huey Yi and Dahlui, Maznah and Shabaruddin, Fatiha Hana and Patrinos, George P. and Mitropoulou, Christina and Williams, Marc S. (2019) Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine. Public Health Genomics, 21 (5-6). pp. 217-227. ISSN 1662-4246, DOI https://doi.org/10.1159/000500725.
Chong, Huey Yi and Lim, Yi Heng and Prawjaeng, Juthamas and Tassaneeyakul, Wichittra and Mohamed, Zahurin and Chaiyakunapruk, Nathorn (2017) Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population. Pharmacogenetics and Genomics, 28 (2). pp. 56-67. ISSN 1744-6872, DOI https://doi.org/10.1097/FPC.0000000000000319.
